Note: The COVID-19 situation is continuously evolving; health care professionals can subscribe here to receive updates.
Click HealthFAX to see the most recent notices for health care professionals
Novel coronavirus can cause illness ranging from a very mild, cold-like illness to a severe lung infection. Some common symptoms are:
Some people such as the elderly and those who are immunocompromised may not develop a fever. For these individuals, the presence of new/worse cough or difficulty breathing may be enough to trigger further precautions.
Complications from the 2019 novel coronavirus can include serious conditions, like pneumonia or kidney failure, and in some cases, death.
Clinical Resources
Getting Ready for your COVID-19 Vaccine
COVID-19 Vaccine Screening and Consent Form
COVID-19 Fact Sheet
Moderna COVID-19 Vaccine Directive Template (Revised January 10, 2021)
Pfizer COVID-19 Vaccine Directive Template (Revised January 10, 2021)
Ministry of Health Guidance Documents:
COVID-19 About Vaccines
Ministry of Long-term Care Cover Letter to Long-term Care Home Staff
Ministry of Long-term Care Memo to Long-term Care Homes Participating in the Vaccine Pilot
COVID-19 Vaccine Approval Process and Safety
COVID-19 Administration of Pfizer-BioNTech COVID-19 Vaccine
COVID-19 Vaccine Availability and Rollout
COVID-19 Vaccine Information Sheet Pfizer-BioNtech COVID-19 Vaccine
COVID-19 Guidance for Health Care Settings: Managing Health Care Workers with Symptoms within 48 Hours of Receiving COVID-19 Vaccine
Other Web Links:
COVID-19 Vaccine Information - Public Health Agency of Canada
COVID-19 Vaccines for Ontario - Ontario Ministry of Health
Pfizer-BioNTech COVID-19 Vaccine 9 (tozinameran) Product Monograph
Moderna COVID-19 Vaccine Product Monograph
NACI Recommendations on the use of COVID-19 vaccine(s)
NACI Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
Newest Guidelines/Documents
Accessing Personal Protective Equipment (PPE): If unable to access PPE through the usual suppliers see the Ontario Health: Quick Reference - PPE and Critical Supplies Escalation Process for assistance in requesting from the provincial supply.
Increased frequency of cleaning high-touch surfaces is significant in controlling the spread of microorganisms during a respiratory infection outbreak. Environmental cleaning products registered in Canada with a Drug Identification Number (DIN) and labelled as a broad-spectrum virucide are sufficient for 2019-nCoV. All surfaces, especially those that are horizontal and frequently touched, should be cleaned at least twice daily and when soiled. The healthcare organization's terminal cleaning protocol for cleaning of the patient's room after discharge, transfer, or discontinuation of contact and droplet precautions should be followed.
Public Settings
Case Management
Reporting
Testing
Specimen Collection Information
Other Links
